Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV3 | Q8NET8 | 11/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.39 |
| ▸ | HTR1A | P08908 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD4 | P21917 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30730299 | 0.82 | HTR1A (0.38) | HTR1ADRD2DRD4CNR2 | |
| SCHEMBL30730250 | 0.78 | TRPV3 (0.38) | TRPV3MAPK1 | |
| SCHEMBL30730115 | 0.77 | CNR2 (0.46) | MAPK1HTR1ADRD2DRD4CNR2 | |
| SCHEMBL27326665 | 0.77 | CNR2 (0.46) | MAPK1HTR1ADRD2DRD4CNR2 | |
| SCHEMBL12616252 | 0.70 | TRPV3 (0.59) | TRPV3 | |
| SCHEMBL12539294 | 0.69 | TRPV3 (0.81) | TRPV3 | |
| SCHEMBL30730401 | 0.68 | HTR1A (0.40) | HTR1ADRD2DRD4CNR2KCNH2 | |
| SCHEMBL2371040 | 0.65 | PIK3CD (0.43) | MAPK1HTR1ADRD2DRD4CNR2 | |
| SCHEMBL22899862 | 0.64 | CHRNA7 (0.38) | TRPV3MAPK1HTR1ADRD2DRD4 | |
| SCHEMBL30308868 | 0.64 | MAP2K3 (0.46) | MAPK1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562015-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2024026481-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |